Ditchcarbon
  • Contact
  1. Organizations
  2. Roche Holdings, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 12 days ago

Roche Holdings, Inc.

Company website

Roche Holdings, Inc., commonly referred to as Roche, is a leading global healthcare company headquartered in the United States. Founded in 1896, Roche has established a strong presence in the pharmaceutical and diagnostics industries, with significant operations across Europe, Asia, and the Americas. The company is renowned for its innovative approach to personalised medicine, focusing on oncology, immunology, and infectious diseases. Roche's core products include cutting-edge pharmaceuticals and advanced diagnostic tools, which are distinguished by their commitment to research and development. With a robust market position, Roche has achieved numerous milestones, including being a pioneer in biotechnology and maintaining a strong portfolio of blockbuster drugs. The company's dedication to improving patient outcomes solidifies its reputation as a leader in the healthcare sector.

DitchCarbon Score

How does Roche Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Roche Holdings, Inc.'s score of 37 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Let us know if this data was useful to you

Roche Holdings, Inc.'s reported carbon emissions

In 2022, Roche Holdings, Inc. reported total carbon emissions of approximately 74,260 kg CO2e, with Scope 1 emissions accounting for about 17,500 kg CO2e and Scope 3 emissions contributing approximately 56,760 kg CO2e, primarily from business travel. Notably, there were no reported Scope 2 emissions, indicating no purchased electricity emissions for that year. For 2023, Roche's CO2 intensity for Scope 1 and 2 was reported at 500 kg CO2 per employee, while in 2025, the company indicated a Scope 1 and 2 GHG emissions figure of 0.4 kg CO2 per employee. This suggests a significant focus on reducing emissions per employee over time. Roche Holdings, Inc. is a current subsidiary of Roche Holding AG, which may influence its climate commitments and reporting. However, there are currently no specific reduction targets or climate pledges disclosed by Roche Holdings, Inc. or cascaded from Roche Holding AG. The absence of formal targets highlights a potential area for future development in their sustainability strategy.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Roche Holdings, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Roche Holdings, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Roche Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hologic

US
•
Research and development services (73)
Updated 6 days ago

Guardant Health

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Biomerieux

FR
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Myriad Genetics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 15 hours ago

Agilent

US
•
Other services (93)
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251024.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy